{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:06:28Z","timestamp":1788303988468,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-022-01446-9","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T10:03:08Z","timestamp":1658829788000},"page":"531-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-6178","authenticated-orcid":false,"given":"John E.","family":"Greenlee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Robert","family":"Brashear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"1446_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/brain\/57.2.161","volume":"57","author":"JG Greenfield","year":"1934","unstructured":"Greenfield JG. Subacute cerebellar degeneration associated with neoplasms. Brain. 1934;57:161\u201376.","journal-title":"Brain"},{"key":"1446_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/brain\/88.3.465","volume":"88","author":"WR Brain","year":"1965","unstructured":"Brain WR, Wilkinson M. Subacute cerebellar degeneration associated with neoplasms. Brain. 1965;88:465\u201378.","journal-title":"Brain"},{"key":"1446_CR3","first-page":"314","volume-title":"Cancer and the nervous system: the neurological manifestations of systemic malignant disease","author":"RA Henson","year":"1982","unstructured":"Henson RA, Urich H. Encephalomyelitis with carcinoma. In: Henson RA, Urich H, editors. Cancer and the nervous system: the neurological manifestations of systemic malignant disease. Oxford: Blackwell Scientific Publications; 1982. p. 314\u201345."},{"key":"1446_CR4","first-page":"346","volume-title":"Cancer and the nervous system: the neurological manifestations of systemic malignant disease","author":"RA Henson","year":"1982","unstructured":"Henson RA, Urich H. Cortical cerebellar degeneration. In: Henson RA, Urich H, editors. Cancer and the nervous system: the neurological manifestations of systemic malignant disease. Oxford: Blackwell Scientific Publications; 1982. p. 346\u201367."},{"key":"1446_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/brain\/88.3.529","volume":"88","author":"PC Wilkinson","year":"1965","unstructured":"Wilkinson PC, Zeromski J. Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain. 1965;88:529\u201338.","journal-title":"Brain"},{"key":"1446_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","volume":"33","author":"JL Trotter","year":"1976","unstructured":"Trotter JL, Hendin BA, Osterland K. Cerebellar degeneration with Hodgkin disease: an immunological study. Arch Neurol. 1976;33:660\u20131.","journal-title":"Arch Neurol"},{"key":"1446_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00005072-198809000-00007","volume":"47","author":"JE Greenlee","year":"1988","unstructured":"Greenlee JE, Brashear HR, Herndon RM. Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. J Neuropathol Exp Neurol. 1988;47:561\u201371.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1446_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ana.410140603","volume":"14","author":"JE Greenlee","year":"1983","unstructured":"Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983;14:609\u201313.","journal-title":"Ann Neurol"},{"key":"1446_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ana.410180513","volume":"18","author":"KA Jaeckle","year":"1985","unstructured":"Jaeckle KA, Graus F, Houghton A, Cordon-Cardo C, Nielsen SL, Posner JB. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic antigen. Ann Neurol. 1985;18:592\u2013600.","journal-title":"Ann Neurol"},{"key":"1446_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1212\/WNL.35.4.538","volume":"35","author":"F Graus","year":"1985","unstructured":"Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology. 1985;35:538\u201343.","journal-title":"Neurology"},{"key":"1446_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.410190117","volume":"19","author":"JE Greenlee","year":"1986","unstructured":"Greenlee JE, Lipton HK. Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. Ann Neurol. 1986;19:82\u20135.","journal-title":"Ann Neurol"},{"key":"1446_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/archneur.1986.00520110055016","volume":"43","author":"KB Digre","year":"1986","unstructured":"Digre KB. Opsoclonus in adults: report of three cases and review of the literature. Arch Neurol. 1986;43:1165\u201375.","journal-title":"Arch Neurol"},{"key":"1446_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.410290303","volume":"29","author":"FA Luque","year":"1991","unstructured":"Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, Schold SC Jr, et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol. 1991;29:241\u201351.","journal-title":"Ann Neurol"},{"key":"1446_CR14","doi-asserted-by":"publisher","first-page":"744653","DOI":"10.3389\/fneur.2021.744653","volume":"12","author":"JE Greenlee","year":"2021","unstructured":"Greenlee JE, Carlson NG, Abbatemarco JR, Herdlev\u00e6r I, Clardy SL, Vedeler CA. Paraneoplastic and other autoimmune encephalitides: antineuronal antibodies, T lymphocytes, and questions of pathogenesis. Front Neurol. 2021;12:744653. https:\/\/doi.org\/10.3389\/fneur.2021.744653.","journal-title":"Front Neurol"},{"key":"1446_CR15","doi-asserted-by":"publisher","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8. https:\/\/doi.org\/10.1212\/nxi.0000000000001014.","DOI":"10.1212\/nxi.0000000000001014"},{"key":"1446_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","volume":"321","author":"D Dubey","year":"2018","unstructured":"Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, et al. Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1-year. J Neuroimmunol. 2018;321:157\u201363. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.016.","journal-title":"J Neuroimmunol"},{"key":"1446_CR17","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1212\/wnl.0000000000013087","volume":"98","author":"A Gravier-Dumonceau","year":"2022","unstructured":"Gravier-Dumonceau A, Ameli R, Rogemond V, Ruiz A, Joubert B, Mu\u00f1iz-Castrillo S, et al. Glial fibrillary acidic protein autoimmunity: a French cohort study. Neurology. 2022;98:e653\u201368. https:\/\/doi.org\/10.1212\/wnl.0000000000013087.","journal-title":"Neurology"},{"key":"1446_CR18","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1212\/wnl.0000000000003414","volume":"87","author":"J Dalmau","year":"2016","unstructured":"Dalmau J. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture. Neurology. 2016;87:2471\u201382. https:\/\/doi.org\/10.1212\/wnl.0000000000003414.","journal-title":"Neurology"},{"key":"1446_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/archneur.1994.00540180033010","volume":"51","author":"C Hida","year":"1994","unstructured":"Hida C, Tsukamoto T, Awano H, Yamamoto T. Ultrastructural localization of anti-Purkinje cell antibody- binding sites in paraneoplastic cerebellar degeneration. Arch Neurol. 1994;51:555\u20138.","journal-title":"Arch Neurol"},{"key":"1446_CR20","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1212\/WNL.38.9.1380","volume":"38","author":"M Rodriguez","year":"1988","unstructured":"Rodriguez M, Truh LI, O\u2019Neill BP, Lennon VA. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.\u00a0Neurol. 1988;38:1380\u20136.","journal-title":"Neurology"},{"key":"1446_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0022-510X(91)90198-G","volume":"106","author":"F Graus","year":"1991","unstructured":"Graus F, Illa I, Agusta M, Ribalta T, Cruz-Sanchez F, Juarez C. Effect of intraventricular injection of anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci. 1991;106:82\u20137.","journal-title":"J Neurol Sci"},{"key":"1446_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00309627","volume":"89","author":"JE Greenlee","year":"1995","unstructured":"Greenlee JE, Burns JB, Rose JW, Jaeckle KA, Clawson S. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol. 1995;89:341\u20135.","journal-title":"Acta Neuropathol"},{"key":"1446_CR23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/NEN.0b013e3181f0c82b","volume":"69","author":"JE Greenlee","year":"2010","unstructured":"Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol. 2010;69:997\u20131007. https:\/\/doi.org\/10.1097\/NEN.0b013e3181f0c82b.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1446_CR24","doi-asserted-by":"publisher","first-page":"e0123446","DOI":"10.1371\/journal.pone.0123446","volume":"10","author":"JE Greenlee","year":"2015","unstructured":"Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, et al. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. PLoS ONE. 2015;10:e0123446. https:\/\/doi.org\/10.1371\/journal.pone.0123446.","journal-title":"PLoS ONE"},{"key":"1446_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/nan.12492","volume":"45","author":"D Panja","year":"2019","unstructured":"Panja D, Vedeler CA, Schubert M. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity. Neuropathol Appl Neurobiol. 2019;45:141\u201356. https:\/\/doi.org\/10.1111\/nan.12492.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1446_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00401-014-1351-6","volume":"128","author":"M Schubert","year":"2014","unstructured":"Schubert M, Panja D, Haugen M, Bramham CR, Vedeler CA. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathol. 2014;128:835\u201352. https:\/\/doi.org\/10.1007\/s00401-014-1351-6.","journal-title":"Acta Neuropathol"},{"key":"1446_CR27","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/acn3.51212","volume":"7","author":"I Herdlevaer","year":"2020","unstructured":"Herdlevaer I, Kr\u00e5kenes T, Schubert M, Vedeler CA. Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration. Ann Clin Transl Neurol. 2020;7:2231\u201342. https:\/\/doi.org\/10.1002\/acn3.51212.","journal-title":"Ann Clin Transl Neurol"},{"key":"1446_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-017-1802-y","volume":"135","author":"M Small","year":"2018","unstructured":"Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, et al. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. Acta Neuropathol. 2018;135:569\u201379. https:\/\/doi.org\/10.1007\/s00401-017-1802-y.","journal-title":"Acta Neuropathol"},{"key":"1446_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41416-018-0125-7","volume":"119","author":"C de VialattePemille","year":"2018","unstructured":"de VialattePemille C, Berzero G, Small M, Psimaras D, Giry M, Daniau M, et al. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies. Br J Cancer. 2018;119:105\u201313. https:\/\/doi.org\/10.1038\/s41416-018-0125-7.","journal-title":"Br J Cancer"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01446-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T05:47:33Z","timestamp":1687931253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01446-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01446-9","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"7 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}